Genmab: Orphan Drug Designation for Epcoritamab

Genmab: Orphan Drug Designation for Epcoritamab

Genmab A/S has announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the investigational medicine epcoritamab (DuoBody®-CD3xCD20) to treat follicular lymphoma (FL). FL is usually a slow-growing or indolent form of...